Taeko Osawa
Overview
Explore the profile of Taeko Osawa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
118
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Osawa T, Fujihara K, Yamada M, Yaguchi Y, Sato T, Kitazawa M, et al.
Diabetol Int
. 2024 Oct;
15(4):786-793.
PMID: 39469557
Aims: To clarify the impact of Breslow's scores consisting of only lifestyle habits or American Heart Association's (AHA) Life's Simple 7 scores consisting of lifestyle habits and control targets on...
2.
Murai K, Fujihara K, Yamada M, Matsubayashi Y, Yamada T, Iwanaga M, et al.
Diabetol Int
. 2024 Aug;
15(3):456-464.
PMID: 39101183
Aims: To evaluate and compare the association of incident cardiovascular disease (CVD) with the Health Practice Index (HPI) reflecting only lifestyle habits and Ideal Cardiovascular Health Metrics (ICVHMs) consisting of...
3.
Oe M, Fujihara K, Yamada M, Osawa T, Kitazawa M, Matsubayashi Y, et al.
J Diabetes Investig
. 2024 Aug;
15(10):1464-1471.
PMID: 39087859
Aims/introduction: History of coronary artery disease (CAD), cerebrovascular disease (CeVD), type 2 diabetes and their combined effect on cardiovascular disease are essential for cardiovascular risk management. We investigated the association...
4.
Kitazawa M, Takeda Y, Hatta M, Horikawa C, Sato T, Osawa T, et al.
J Clin Endocrinol Metab
. 2023 Nov;
109(4):1060-1070.
PMID: 37931069
Aims: Although conventional interventions for people at high risk of developing type 2 diabetes are usually conducted face-to-face, such interventions are burdensome for health care providers. We developed a lifestyle...
5.
Ikeda I, Fujihara K, Osawa T, Takeda Y, Hatta M, Matsubayashi Y, et al.
BMJ Open Diabetes Res Care
. 2023 Jul;
11(4).
PMID: 37437950
Introduction: Low serum amylase values are cross-sectionally associated with the prevalence of type 2 diabetes mellitus (T2DM) but have not been shown to be longitudinally associated with its incidence. This...
6.
Sato T, Fujihara K, Yamada M, Chou K, Yaguchi Y, Kitazawa M, et al.
J Sports Sci Med
. 2023 Mar;
22(1):98-110.
PMID: 36876177
We developed a new Physical Score (PS) consisting of comprehensive physical fitness indicators and elucidated the association between the resultant PS and metabolic diseases, i.e., diabetes, hypertension, dyslipidemia, fatty liver,...
7.
Osawa T, Fujihara K, Yamada M, Yaguchi Y, Sato T, Kitazawa M, et al.
Diabetol Int
. 2023 Jan;
14(1):86-93.
PMID: 36636159
Aims: To determine the associations between combined urinary protein (UP) and a reduced estimated glomerular filtration rate (eGFR) and the risk of starting dialysis with or without diabetes mellitus (DM)....
8.
Matsubayashi Y, Fujihara K, Yamada-Harada M, Mitsuma Y, Sato T, Yaguchi Y, et al.
Cardiovasc Diabetol
. 2022 Jun;
21(1):90.
PMID: 35655263
Background: To determine the impact of metabolic syndrome (MetS) and/or metabolic dysfunction-associated fatty liver disease (MAFLD), which are pathophysiologically similar and include insulin resistance, on the development of new-onset cardiovascular...
9.
Oe M, Fujihara K, Harada-Yamada M, Osawa T, Kitazawa M, Matsubayashi Y, et al.
Cardiovasc Diabetol
. 2021 Sep;
20(1):174.
PMID: 34479567
Background: Although both a history of cerebrovascular disease (CVD) and glucose abnormality are risk factors for CVD, few large studies have examined their association with subsequent CVD in the same...
10.
Yamada M, Fujihara K, Kodama S, Sato T, Osawa T, Yaguchi Y, et al.
Diabetes Care
. 2021 May;
44(9):2124-2131.
PMID: 34035075
Objective: To determine associations of systolic blood pressure (SBP) and diastolic blood pressure (DBP) with new-onset coronary artery disease (CAD) or cerebrovascular disease (CVD) according to glucose status. Research Design...